Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Active Pharmaceutical Ingredient market report explains the definition, types, applications, major countries, and major players of the Active Pharmaceutical Ingredient market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Shandong Lukang Pharmaceutical
Cipla
Boehringer Ingelheim GmbH
Jiangsu Hengrui Medicine
Lupin
Aurobindo pharma
Johnson Matthey
Bachem
Cambrex
Teva
Johnson & Johnson
Pfizer
Sun Pharmaceutical Industries
Novartis
North East Pharmaceutical
Bayer
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Mylan
Tian Yao
Biocon
Hisun Pharmacy
Zhejiang Medicine
Roche
DSM
BASF
Albemarle
Lonza group
North China Pharmaceutical Group
Shandong Xinhua Pharmaceutical
By Type:
Synthetic Active Pharmaceutical Ingredient
Biotech Active Pharmaceutical Ingredient
Other
By End-User:
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Active Pharmaceutical Ingredient Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Active Pharmaceutical Ingredient Outlook to 2028- Original Forecasts
-
2.2 Active Pharmaceutical Ingredient Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Active Pharmaceutical Ingredient Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Active Pharmaceutical Ingredient Market- Recent Developments
-
6.1 Active Pharmaceutical Ingredient Market News and Developments
-
6.2 Active Pharmaceutical Ingredient Market Deals Landscape
7 Active Pharmaceutical Ingredient Raw Materials and Cost Structure Analysis
-
7.1 Active Pharmaceutical Ingredient Key Raw Materials
-
7.2 Active Pharmaceutical Ingredient Price Trend of Key Raw Materials
-
7.3 Active Pharmaceutical Ingredient Key Suppliers of Raw Materials
-
7.4 Active Pharmaceutical Ingredient Market Concentration Rate of Raw Materials
-
7.5 Active Pharmaceutical Ingredient Cost Structure Analysis
-
7.5.1 Active Pharmaceutical Ingredient Raw Materials Analysis
-
7.5.2 Active Pharmaceutical Ingredient Labor Cost Analysis
-
7.5.3 Active Pharmaceutical Ingredient Manufacturing Expenses Analysis
8 Global Active Pharmaceutical Ingredient Import and Export Analysis (Top 10 Countries)
-
8.1 Global Active Pharmaceutical Ingredient Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Active Pharmaceutical Ingredient Export by Region (Top 10 Countries) (2017-2028)
9 Global Active Pharmaceutical Ingredient Market Outlook by Types and Applications to 2022
-
9.1 Global Active Pharmaceutical Ingredient Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Synthetic Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biotech Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Active Pharmaceutical Ingredient Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Drugs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Anti-diabetic Drugs Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Drugs Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Central Nervous System Drugs (CNS Drugs) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Musculoskeletal Drugs Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Drugs Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Active Pharmaceutical Ingredient Market Analysis and Outlook till 2022
-
10.1 Global Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.2.2 Canada Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.2.3 Mexico Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.2 UK Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.3 Spain Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.4 Belgium Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.5 France Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.6 Italy Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.7 Denmark Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.8 Finland Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.9 Norway Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.10 Sweden Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.11 Poland Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.12 Russia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.3.13 Turkey Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.2 Japan Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.3 India Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.4 South Korea Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.5 Pakistan Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.6 Bangladesh Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.7 Indonesia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.8 Thailand Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.9 Singapore Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.10 Malaysia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.11 Philippines Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.4.12 Vietnam Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.2 Colombia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.3 Chile Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.4 Argentina Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.5 Venezuela Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.6 Peru Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.7 Puerto Rico Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.5.8 Ecuador Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6.2 Kuwait Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6.3 Oman Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6.4 Qatar Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6.5 Saudi Arabia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.6.6 United Arab Emirates Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.7.2 South Africa Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.7.3 Egypt Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.7.4 Algeria Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Active Pharmaceutical Ingredient Consumption (2017-2022)
-
10.8.2 New Zealand Active Pharmaceutical Ingredient Consumption (2017-2022)
11 Global Active Pharmaceutical Ingredient Competitive Analysis
-
11.1 Shandong Lukang Pharmaceutical
-
11.1.1 Shandong Lukang Pharmaceutical Company Details
-
11.1.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.1.4 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Cipla
-
11.2.1 Cipla Company Details
-
11.2.2 Cipla Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Cipla Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.2.4 Cipla Active Pharmaceutical Ingredient Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Boehringer Ingelheim GmbH
-
11.3.1 Boehringer Ingelheim GmbH Company Details
-
11.3.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.3.4 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Jiangsu Hengrui Medicine
-
11.4.1 Jiangsu Hengrui Medicine Company Details
-
11.4.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.4.4 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Lupin
-
11.5.1 Lupin Company Details
-
11.5.2 Lupin Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Lupin Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.5.4 Lupin Active Pharmaceutical Ingredient Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Aurobindo pharma
-
11.6.1 Aurobindo pharma Company Details
-
11.6.2 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Aurobindo pharma Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.6.4 Aurobindo pharma Active Pharmaceutical Ingredient Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Johnson Matthey
-
11.7.1 Johnson Matthey Company Details
-
11.7.2 Johnson Matthey Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Johnson Matthey Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.7.4 Johnson Matthey Active Pharmaceutical Ingredient Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bachem
-
11.8.1 Bachem Company Details
-
11.8.2 Bachem Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bachem Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.8.4 Bachem Active Pharmaceutical Ingredient Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Cambrex
-
11.9.1 Cambrex Company Details
-
11.9.2 Cambrex Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Cambrex Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.9.4 Cambrex Active Pharmaceutical Ingredient Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Teva
-
11.10.1 Teva Company Details
-
11.10.2 Teva Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Teva Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.10.4 Teva Active Pharmaceutical Ingredient Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Johnson & Johnson
-
11.11.1 Johnson & Johnson Company Details
-
11.11.2 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Johnson & Johnson Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.11.4 Johnson & Johnson Active Pharmaceutical Ingredient Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Pfizer
-
11.12.1 Pfizer Company Details
-
11.12.2 Pfizer Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Pfizer Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.12.4 Pfizer Active Pharmaceutical Ingredient Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sun Pharmaceutical Industries
-
11.13.1 Sun Pharmaceutical Industries Company Details
-
11.13.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.13.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Novartis
-
11.14.1 Novartis Company Details
-
11.14.2 Novartis Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Novartis Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.14.4 Novartis Active Pharmaceutical Ingredient Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 North East Pharmaceutical
-
11.15.1 North East Pharmaceutical Company Details
-
11.15.2 North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 North East Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.15.4 North East Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Bayer
-
11.16.1 Bayer Company Details
-
11.16.2 Bayer Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Bayer Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.16.4 Bayer Active Pharmaceutical Ingredient Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Huahai Pharmaceutical
-
11.17.1 Huahai Pharmaceutical Company Details
-
11.17.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.17.4 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Haerbin Pharmaceutical Group
-
11.18.1 Haerbin Pharmaceutical Group Company Details
-
11.18.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.18.4 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Mylan
-
11.19.1 Mylan Company Details
-
11.19.2 Mylan Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Mylan Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.19.4 Mylan Active Pharmaceutical Ingredient Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Tian Yao
-
11.20.1 Tian Yao Company Details
-
11.20.2 Tian Yao Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Tian Yao Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.20.4 Tian Yao Active Pharmaceutical Ingredient Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Biocon
-
11.21.1 Biocon Company Details
-
11.21.2 Biocon Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Biocon Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.21.4 Biocon Active Pharmaceutical Ingredient Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Hisun Pharmacy
-
11.22.1 Hisun Pharmacy Company Details
-
11.22.2 Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Hisun Pharmacy Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.22.4 Hisun Pharmacy Active Pharmaceutical Ingredient Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Zhejiang Medicine
-
11.23.1 Zhejiang Medicine Company Details
-
11.23.2 Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Zhejiang Medicine Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.23.4 Zhejiang Medicine Active Pharmaceutical Ingredient Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Roche
-
11.24.1 Roche Company Details
-
11.24.2 Roche Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Roche Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.24.4 Roche Active Pharmaceutical Ingredient Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 DSM
-
11.25.1 DSM Company Details
-
11.25.2 DSM Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 DSM Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.25.4 DSM Active Pharmaceutical Ingredient Product Portfolio
-
11.25.5 Recent Research and Development Strategies
-
11.26 BASF
-
11.26.1 BASF Company Details
-
11.26.2 BASF Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.26.3 BASF Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.26.4 BASF Active Pharmaceutical Ingredient Product Portfolio
-
11.26.5 Recent Research and Development Strategies
-
11.27 Albemarle
-
11.27.1 Albemarle Company Details
-
11.27.2 Albemarle Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.27.3 Albemarle Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.27.4 Albemarle Active Pharmaceutical Ingredient Product Portfolio
-
11.27.5 Recent Research and Development Strategies
-
11.28 Lonza group
-
11.28.1 Lonza group Company Details
-
11.28.2 Lonza group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.28.3 Lonza group Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.28.4 Lonza group Active Pharmaceutical Ingredient Product Portfolio
-
11.28.5 Recent Research and Development Strategies
-
11.29 North China Pharmaceutical Group
-
11.29.1 North China Pharmaceutical Group Company Details
-
11.29.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.29.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.29.4 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Portfolio
-
11.29.5 Recent Research and Development Strategies
-
11.30 Shandong Xinhua Pharmaceutical
-
11.30.1 Shandong Xinhua Pharmaceutical Company Details
-
11.30.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
11.30.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
11.30.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
11.30.5 Recent Research and Development Strategies
12 Global Active Pharmaceutical Ingredient Market Outlook by Types and Applications to 2028
-
12.1 Global Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Synthetic Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Biotech Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Anti-diabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cardiovascular Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Central Nervous System Drugs (CNS Drugs) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Musculoskeletal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Active Pharmaceutical Ingredient Market Analysis and Outlook to 2028
-
13.1 Global Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.2.2 Canada Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.2.3 Mexico Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.2 UK Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.3 Spain Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.4 Belgium Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.5 France Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.6 Italy Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.7 Denmark Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.8 Finland Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.9 Norway Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.10 Sweden Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.11 Poland Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.12 Russia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.3.13 Turkey Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.2 Japan Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.3 India Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.4 South Korea Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.8 Thailand Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.9 Singapore Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.11 Philippines Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.2 Colombia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.3 Chile Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.4 Argentina Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.6 Peru Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6.3 Oman Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6.4 Qatar Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.7.2 South Africa Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.7.3 Egypt Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.7.4 Algeria Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Active Pharmaceutical Ingredient
-
Figure of Active Pharmaceutical Ingredient Picture
-
Table Global Active Pharmaceutical Ingredient Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Active Pharmaceutical Ingredient Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Synthetic Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Global Biotech Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-diabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Drugs (CNS Drugs) Consumption and Growth Rate (2017-2022)
-
Figure Global Musculoskeletal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Table North America Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure United States Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Canada Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Mexico Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table Europe Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure Germany Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure UK Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Spain Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Belgium Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure France Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Italy Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Denmark Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Finland Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Norway Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Sweden Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Poland Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Russia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Turkey Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table APAC Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure China Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Japan Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure India Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure South Korea Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Thailand Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Singapore Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Philippines Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table South America Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure Brazil Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Colombia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Chile Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Argentina Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Peru Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table GCC Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure Bahrain Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Oman Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Qatar Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table Africa Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure Nigeria Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure South Africa Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Egypt Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure Algeria Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table Oceania Active Pharmaceutical Ingredient Consumption by Country (2017-2022)
-
Figure Australia Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)
-
Table Shandong Lukang Pharmaceutical Company Details
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
Table Cipla Company Details
-
Table Cipla Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Cipla Active Pharmaceutical Ingredient Product Portfolio
-
Table Boehringer Ingelheim GmbH Company Details
-
Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Portfolio
-
Table Jiangsu Hengrui Medicine Company Details
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Lupin Active Pharmaceutical Ingredient Product Portfolio
-
Table Aurobindo pharma Company Details
-
Table Aurobindo pharma Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo pharma Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Aurobindo pharma Active Pharmaceutical Ingredient Product Portfolio
-
Table Johnson Matthey Company Details
-
Table Johnson Matthey Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson Matthey Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Johnson Matthey Active Pharmaceutical Ingredient Product Portfolio
-
Table Bachem Company Details
-
Table Bachem Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bachem Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Bachem Active Pharmaceutical Ingredient Product Portfolio
-
Table Cambrex Company Details
-
Table Cambrex Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cambrex Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Cambrex Active Pharmaceutical Ingredient Product Portfolio
-
Table Teva Company Details
-
Table Teva Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Teva Active Pharmaceutical Ingredient Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Johnson & Johnson Active Pharmaceutical Ingredient Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Pfizer Active Pharmaceutical Ingredient Product Portfolio
-
Table Sun Pharmaceutical Industries Company Details
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Novartis Active Pharmaceutical Ingredient Product Portfolio
-
Table North East Pharmaceutical Company Details
-
Table North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table North East Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table North East Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Bayer Active Pharmaceutical Ingredient Product Portfolio
-
Table Huahai Pharmaceutical Company Details
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
Table Haerbin Pharmaceutical Group Company Details
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Mylan Active Pharmaceutical Ingredient Product Portfolio
-
Table Tian Yao Company Details
-
Table Tian Yao Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tian Yao Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Tian Yao Active Pharmaceutical Ingredient Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Biocon Active Pharmaceutical Ingredient Product Portfolio
-
Table Hisun Pharmacy Company Details
-
Table Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hisun Pharmacy Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Hisun Pharmacy Active Pharmaceutical Ingredient Product Portfolio
-
Table Zhejiang Medicine Company Details
-
Table Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhejiang Medicine Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Zhejiang Medicine Active Pharmaceutical Ingredient Product Portfolio
-
Table Roche Company Details
-
Table Roche Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Roche Active Pharmaceutical Ingredient Product Portfolio
-
Table DSM Company Details
-
Table DSM Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table DSM Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table DSM Active Pharmaceutical Ingredient Product Portfolio
-
Table BASF Company Details
-
Table BASF Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table BASF Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table BASF Active Pharmaceutical Ingredient Product Portfolio
-
Table Albemarle Company Details
-
Table Albemarle Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Albemarle Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Albemarle Active Pharmaceutical Ingredient Product Portfolio
-
Table Lonza group Company Details
-
Table Lonza group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza group Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Lonza group Active Pharmaceutical Ingredient Product Portfolio
-
Table North China Pharmaceutical Group Company Details
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Portfolio
-
Table Shandong Xinhua Pharmaceutical Company Details
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Main Business and Markets Served
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Portfolio
-
Figure Global Synthetic Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotech Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-diabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Drugs (CNS Drugs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Musculoskeletal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Table North America Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure United States Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure Germany Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure China Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure Brazil Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)
-
Figure Australia Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)
-
